Post-approval studies (Phase 4)Study completedNCT00736515
What this trial is testing
Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
Who this might be right for
Type 2 Diabetes
Servier (Tianjin) Pharmaceutical Co. LTD. 160